Name - ENDRA Life Sciences Inc
Current / Former Name: ENDRA Life Sciences Inc (Current)
Address: 3600 Green Court, Suite 350, Ann Arbor, MI 48105
Phone Number: (734) 335-0831
Investor Relations : NDRA@lhai.com
Website - https://www.endralifesciences.com
Warrant Symbol: NDRAW
Warrants Listed: 1,980,000
Ratio: 1-for-1
Cusip Number: 29273B 11 2
ISIN Number: US29273B1124
Parent Stock Symbol: NDRA (NASDAQ)
Underlying Stock CUSIP: 29273B 401 (Updated following 1-for-50 reverse split)
Expiry Date - May 9, 2022
Exercise Price: $6.25
Synopsis & Listing Information
Synopsis: ENDRA Life Sciences Inc. develops Thermo Acoustic Enhanced UltraSound (TAEUS) technology designed to visually characterize tissue and monitor a variety of clinical conditions, specializing in non-alcoholic fatty liver disease.
Listing History: The warrants were issued via the company's initial public offering on May 9, 2017, and were immediately distributed for secondary market access on the NASDAQ Capital Market using the symbol NDRAW.
Business Combination: N/A
Ticker Change: N/A
Reverse Split Adjustment: N/A
Current Status: INACTIVE. The public retail warrants hit their absolute lifetime boundary parameters on May 9, 2022, and expired unexercised from the active registry.
Current / Former Name: ENDRA Life Sciences Inc (Current)
Address: 3600 Green Court, Suite 350, Ann Arbor, MI 48105
Phone Number: (734) 335-0831
Investor Relations : NDRA@lhai.com
Website - https://www.endralifesciences.com
Warrant Symbol: NDRAW
Warrants Listed: 1,980,000
Ratio: 1-for-1
Cusip Number: 29273B 11 2
ISIN Number: US29273B1124
Parent Stock Symbol: NDRA (NASDAQ)
Underlying Stock CUSIP: 29273B 401 (Updated following 1-for-50 reverse split)
Expiry Date - May 9, 2022
Exercise Price: $6.25
Synopsis & Listing Information
Synopsis: ENDRA Life Sciences Inc. develops Thermo Acoustic Enhanced UltraSound (TAEUS) technology designed to visually characterize tissue and monitor a variety of clinical conditions, specializing in non-alcoholic fatty liver disease.
Listing History: The warrants were issued via the company's initial public offering on May 9, 2017, and were immediately distributed for secondary market access on the NASDAQ Capital Market using the symbol NDRAW.
Business Combination: N/A
Ticker Change: N/A
Reverse Split Adjustment: N/A
Current Status: INACTIVE. The public retail warrants hit their absolute lifetime boundary parameters on May 9, 2022, and expired unexercised from the active registry.
American Financial News
Loading the latest American market news...
American Financial News
Loading the latest American market news...